2009 BIOL503 Class 6, Part 1: Intellectual Property II: Subject Matter, Life forms; purified natural products

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

0 comments

Post a comment

    Post a comment
    Embed Video
    Edit your comment Cancel

    1 Group

    2009 BIOL503 Class 6, Part 1: Intellectual Property II: Subject Matter, Life forms; purified natural products - Presentation Transcript

    1. Intellectual Property II: Subject Matter CSUCI2009 BIOL503 K. Pessin
    2. Intellectual Property II: Subject Matter Biological compositions and methods CSUCI2009 BIOL503 K. Pessin
    3. Intellectual Property II
      • Subject Matter
        • Biological compositions and methods
        • Electronic, business methods, computer and software related
      • Utility requirement
      • “ Newness”
        • Novelty
        • Non-obviousness
      • Inventorship
    4. Intellectual Property II
      • Objective of this section
        • Understand subject matter than can be patented
        • Understand basics of patent laws for biological materials
        • Review specific case studies – proteins, DNA, stem cells, plants
        • Experience patent searching – stem cell example
    5. Intellectual Property II
    6. Intellectual Property II
      • Subject Matter
      • Utility
      • Novelty
      • Non-Obviousness
    7. Intellectual Property II
    8. Intellectual Property II: Patents, Subject Matter
      • 35 U.S.C. §101 Inventions patentable .
      • Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter , . . . may obtain a patent therefor, . . ..
    9. Intellectual Property II: Patents, Subject Matter
      • "Everything under the Sun. . .
      • made by Man”
      http://cmex.ihmc.us/CMEX/data/images/Vik2ls.gif
    10. Intellectual Property II, Patentable subject matter: Life forms
      • Generally
      • Purified Products of Nature
        • Proteins
          • Case study: Factor VIII case study
        • DNA, nucleic acids
          • Case study: Erythropoietin Case Study
      • Life forms
        • Microbial/Cellular
          • Chakrabarty case
        • Animals, Humans, Chimera, Synthetic
          • Stem cell patent search
        • Plants
          • Case study: Superior Seedless
    11. Intellectual Property II, Patentable subject matter: Life forms
      • Generally
        • Prometheus- personalized medicine case
      • Purified Products of Nature
        • Proteins
          • Case study: Factor VIII case study
        • DNA, nucleic acids
          • Case study: Erythropoietin Case Study
      • Life forms
        • Microbial/Cellular
          • Chakrabarty case
        • Animals, Humans, Chimera, Synthetic
          • Stem cell patent search
        • Plants
          • Case study: Superior Seedless
    12. Intellectual Property II: Patents, Subject Matter
      • Unpatentable subject matter:
        • Laws of Nature
        • Abstract Ideas
        • Mathematical Algorithms
        • Mental Steps
        • Printed Matter
      • Other reasons for unpatentability. . .
    13. Intellectual Property II: Patents, Subject Matter
      • Personalized medicine: testing a patient’s response to a drug as a natural phenomenon ?
      • Prometheus v. Mayo (S.D.Cal.2008) : Testing drug metabolite in patient to determine the correct dose for that patient is an unpatentable natural phenomenon.
    14. Intellectual Property II: Patents, Subject Matter
      • Prometheus v. Mayo (S.D.Cal.2008 )U.S. Patent No. 6,355,623 claim 1: A method of optimizing therapeutic efficacy for treatment of an immune-mediated gastrointestinal disorder, comprising:
      • (a) administering a drug providing 6-thioguanine to a subject having said immune-mediated gastrointestinal disorder; and
      • (b) determining the level of 6-thioguanine in said subject having said immune-mediated gastrointestinal disorder,
      • wherein the level of 6-thioguanine less than about 230 pmol per 8 x 108 red blood cells indicates a need to increase the amount of said drug subsequently administered to said subject and
      • wherein the level of 6-thioguanine greater than about 400 pmol per 8 x 108 red blood cells indicates a need to decrease the amount of said drug subsequently administered to said subject.
      Personalized medicine - Natural phenomenon?
    15. Intellectual Property II, Patentable subject matter: Life forms
      • Generally
      • Purified Products of Nature
        • Proteins
          • Case study: Factor VIII case study
        • DNA, nucleic acids
          • Case study: Erythropoietin Case Study
      • Life forms
        • Microbial/Cellular
          • Chakrabarty case
        • Animals, Humans, Chimera, Synthetic
          • Stem cell patent search
        • Plants
          • Case study: Superior Seedless
    16. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature
      • Issue: Are purified products of nature patentable?
      • Answer: Yes.
      • Adrenaline case: Isolation of adrenaline free of source impurities created a product with new characteristics as compared to the impure product found in nature. Parke-Davis & Co. v. H.K. Mulford & Co., (2d Cir., 1912, Learned Hand )
      Dr. Jokichi Takamine, inventor of first biotech blockbuster, Adrenalin (epinephrine)
    17. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature
      • Natural substances
        • Function may be identified in natural surroundings (e.g., willow bark)
        • Identify desired compound
        • Purify – transforms into material with new characteristics
          • Potency
          • Lack of problems of some sort
      • Example: Scripps v. Genentech, Factor VIII
    18. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature Testimony of Ryan White before the National Commission on AIDS March 3, 1988 Thank You Commissioners: My name is Ryan White. I am sixteen years old. I have Hemophilia, and I have AIDS. When I was three days old, the doctors told my parents I was a severe Hemophiliac, meaning my blood does not clot. Lucky for me, there was product just approved by the Food and Drug Administration. It was called Factorate, which contains the clotting agent found in blood. Ryan White 1971-1990
    19. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature Scripps v. Genentech : Scripps held a patent on “human” Factor VIII, and disclosed how to isolate it from human blood. Genentech: Made recombinant Factor VIII:C using human gene in eukaryotic cell culture. Issue: Is Scripps’ “human” Factor VIII:C pure enough to warrant a patent?
    20. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature http://www.advate.com/evo_factor.html Hemophilia
    21. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature Factor VIII:C from pooled human blood donors: AIDS Recombinant VIII:C made in baby hamster kidney cells: No AIDS
    22. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature In the 1980’s, a heat-treated version of pooled blood Factor VIII was introduced, presumably free of AIDS virus. But blood screening, and heat treating were not always done. http://www.thebody.com/cdc/news_updates_archive/2003/may22_03/hi ... article excerpted from AP 5/22/03
    23. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature
      • Scripps process: use anti-VIII:RP monoclonal to purify Factor VIII:C – claimed to be really super pure compared to the polyclonal purified
      RP Factor VIII:C Anti VIII:RP antibody Polyclonal = prior art Monoclonal = patent
    24. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature “ Discovery” in litigation means investigating facts using special rules for obtaining documents and testimony. Not all facts discovered will be admissible at trial. “ Smoking gun” refers to conclusive evidence of a party’s case (e.g., if the gun is still smoking, it was recently fired..) Notable deponents
    25. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature Scripps claimed “pure” Factor VIII:C in terms of activity or relative purity. Scripps told the patent examiner that their patent taught “essentially pure VIII:C”.
    26. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature But, the inventors did not know the percent contaminants in their Factor VIII:C.
    27. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature Translation: About 50% fibronectin, 50% VIII:C
    28. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature District court: “Scripps, your patent is no good because you lied to the patent office about how pure your Factor VIII:C was in order to get your patent.”
    29. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature
      • Federal Circuit: “Not so fast district court. The district court set the purity bar too high. The patent is valid because the Factor VIII:C taught is pure enough.”
    30. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature
      • Federal Circuit: “But…since recombinant Factor VIII:C is so much more active and pure than blood-derived Factor VIII:C, Genentech, you may have a non-infringement argument.”
    31. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature http://library.corporate-ir.net/library/86/861/86121/items/320405/B00FD3E8-FD7C-4AC1-A4E6-A69942B888BF_BaxterJPMorgan2009.pdf NOTE: SEE FULL DOCUMENT INCLUDING SAFE HARBOR
    32. Intellectual Property II, Patentable subject matter: Life forms
      • Generally
      • Purified Products of Nature
        • Proteins
          • Case study: Factor VIII case study
        • DNA, nucleic acids
          • Case study: Erythropoietin Case Study
      • Life forms
        • Microbial/Cellular
          • Chakrabarty case
        • Animals, Humans, Chimera, Synthetic
          • Stem cell patent search
        • Plants
          • Case study: Superior Seedless
    33. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature This cartoon is fictional because a gene, unless specifically identified and isolated from the surrounding genome, is not patentable subject matter.
    34. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature You can’t patent the DNA! That’s found in nature.
    35. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature Oh look! I have invented the gene encoding erythropoietin ‘cuz it’s in there somewhere! . NO. THIS IS NOT HOW PATENT LAW WORKS
    36. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature DNA is patentable as a chemical compound , not a function.
    37. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature Entire human erythropoietin DNA sequence + plan to fish out the rest of the DNA Genetics Institute
    38. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature Conception: I conceive of the gene encoding erythropoietin Reduction to practice: Now I have the entire DNA coding region! Simultaneous conception and reduction to practice .
    39. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature
      • A gene is a chemical compound, . . . . Conception does not occur unless one has a mental picture of the structure of the chemical. . . . It is not sufficient to define it solely by its principal biological property, e.g. , encoding human erythropoietin, because an alleged conception having no more specificity than that is simply a wish to know the identity of any material with that biological property. We hold that when an inventor is unable to envision the detailed constitution of a gene so as to distinguish it from other materials, as well as a method for obtaining it, conception has not been achieved until reduction to practice has occurred, i.e. , until after the gene has been isolated . Amgen v. Chugai (CAFC 1991)
    40. Intellectual Property II: Patents, Subject Matter, Purified Products of Nature http://www.uspto.gov/web/offices/pac/mpep/documents/2400_2420.htm#sect2420
    41. Quiz
      • Should genes, in purified form, where they have a known activity (and otherwise fulfilling patentability requirements), be patentable?
    42. Intellectual Property II, Patentable subject matter: Life forms
      • Generally
      • Purified Products of Nature
        • Proteins
          • Case study: Factor VIII case study
        • DNA, nucleic acids
          • Case study: Erythropoietin Case Study
      • Life forms
        • Microbial/Cellular
          • Chakrabarty case
        • Animals, Humans, Chimera, Synthetic
          • Stem cell patent search
        • Plants
          • Case study: Superior Seedless
    43. Intellectual Property II: Patents, Subject Matter
      • Issue: Is genetically engineered bacteria patentable?
      • Decision: Yes. Living inventions modified by humans are patentable subject matter.
      • Diamond v. Chakrabarty, Supreme Court 1980
      ’ 80s
      • Test: Whether the living matter is the result of human intervention.
        • [A] new mineral discovered in the earth or a new plant found in the wild is not patentable subject matter. Likewise, Einstein could not patent his celebrated E=mc2; nor could Newton have patented the law of gravity. Such discoveries are "manifestations of . . . nature, free to all men and reserved exclusively to none." * * * [T]he production of articles for use from raw materials prepared by giving to these materials new forms, qualities, properties, or combinations whether by hand labor or by machinery" [emphasis added] is a "manufacture" under 35 U.S.C. 101.
      • Diamond v. Chakrabarty (Supreme Court 1980)
      Intellectual Property II: Patents, Subject Matter, Life Forms
      • While natural laws, physical phenomena, abstract ideas, or newly discovered minerals are not patentable, a live artificially-engineered microorganism is. The creation of a bacterium that is not found anywhere in nature, constitutes a patentable "manufacture" or "composition of matter" under Section 101. Moreover, the bacterium's man-made ability to break down crude oil makes it very useful.
      • Diamond v. Chakrabarty 447 U.S. 303 (1980)
      Intellectual Property II: Patents, Subject Matter, Life Forms
    44. Intellectual Property II: Patents, Subject Matter, Life Forms http://www.uspto.gov/web/offices/pac/mpep/documents/2400_2403.htm#sect2403
    45. Intellectual Property II: Patents, Subject Matter, Organisms
      • Example of composition claims
        • DNA or RNAs
        • Peptides or proteins
        • “ Selective binding molecules”, e.g., antibodies, modified antibodies, peptibodies, etc.
        • Microorganisms newly isolated in pure form from a natural source or genetically engineered microorganisms
        • Transgenic or knock-out animals
    46. Intellectual Property II, Patentable subject matter: Life forms
      • Generally
      • Purified Products of Nature
        • Proteins
          • Case study: Factor VIII case study
        • DNA, nucleic acids
          • Case study: Erythropoietin Case Study
      • Life forms
        • Microbial/Cellular
          • Chakrabarty case
        • Animals, Humans, Chimera, Synthetic
          • Stem cell patent search
        • Plants
          • Case study: Superior Seedless
    47. Intellectual Property II: Patents, Subject Matter, Humans 13 th Amendment to the US Constitution, abolishing property rights in humans Frank Leslie's Illustrated Newspaper, Cover, April 22, 1865, “President Lincoln Riding Through Richmond, April 4, 1865 ”
    48. Intellectual Property II: Patents, Subject Matter, Humans
      • “If the broadest reasonable interpretation of the claimed invention as a whole encompasses a human being, then a rejection under 35 U.S.C. 101 must be made indicating that the claimed invention is directed to nonstatutory subject matter. Furthermore, the claimed invention must be examined with regard to all issues pertinent to patentability, and any applicable rejections under 35 U.S.C. 102 , 103 , or 112 must also be made .”
      http://www.uspto.gov/web/offices/pac/mpep/documents/2100_2105.htm#sect2105 MPEP § 2105
    49. Intellectual Property II: Patents, Subject Matter, Humans Patent office funding law: no money can be used for patents on humans
    50. Intellectual Property II: Patents, Subject Matter, Organisms
      • . . .Chakrabarty puts down the row over patents to what he calls the “mentality” in many developing countries “We never recognise product patents. We think this is how it is always going to be and that we can always copy innovations from industrialised countries,” said the scientist who was educated in the city of Kolkata. “We never send messages to young scientists that they can innovate.” “The US has attracted scientists from other countries because these countries cannot protect their patents.”... http:// www.panos.org.uk/newsfeatures/featureprintable.asp?id =1219
      Dr Ananda Chakrabarty, 26 years later. (Currently associate professor of microbiology at the University of Illinois College of Medicine)
    51. Intellectual Property II: Patents, Subject Matter, Animals
      • Nonnaturally occurring nonhuman multicellular living organisms, including animals are patentable subject matter.
      • E.g., Ex parte Allen , 2 USPQ2d 1425 (Bd. Pat. App. & Inter. 1987), polyploid Pacific coast oyster
      http://www.uspto.gov/web/offices/pac/mpep/documents/2100_2105.htm#sect2105
    52. Intellectual Property II: Patents, Subject Matter, Animals
      • Harvard Oncomouse
      http://www.google.com/patents?vid=USPAT4736866&id=_q47AAAAEBAJ&printsec=abstract&zoom=4&dq=4,736,866#PRA2-PA8-IA1,M1
    53. Intellectual Property II: Patents, Subject Matter, Part Humans
      • What about a human-zee?
      http://www.pbs.org/newshour/bb/science/july-dec05/chimeras_newman-ext.html Stuart Newman, professor of cell biology and anatomy at New York Medical College, tried to patent a human-ape chimera as a way to draw attention to the practice of blending genes. The patent was denied, which was what they wanted, but it does not rule out other kinds of chimeras. + = ?
    54. Intellectual Property II: Patents, Subject Matter, Part Humans Dr. Venter “ Synthetic Biology”
    55. Intellectual Property II: Patents, Subject Matter, Part Humans
    56. Intellectual Property II: Patents, Subject Matter, Part Humans
    57. Intellectual Property II: Patents, Subject Matter, Organisms
      • Example of composition claims
        • DNA , RNAs, vectors, antisense, analogs
        • Peptides or proteins, mimetics
        • “ Selective binding molecules”, e.g., antibodies, modified antibodies, peptibodies, etc.
        • Unicellular organisms, cell culture isolates or genetically modified;
        • Human stem cell cultures; human tissues;
        • Non-human genetically modified , e.g., transgenic, knockout, etc.
    58. Intellectual Property II, Patentable subject matter: Life forms
      • Generally
      • Purified Products of Nature
        • Proteins
          • Case study: Factor VIII case study
        • DNA, nucleic acids
          • Case study: Erythropoietin Case Study
      • Life forms
        • Microbial/Cellular
          • Chakrabarty case
        • Animals, Humans, Chimera, Synthetic
          • Stem cell patent search
        • Plants
          • Case study: Superior Seedless
    59. Intellectual Property II: Patents, Subject Matter, Human Parts This cartoon could be true because manufactured body parts are patentable.
    60. Intellectual Property II: Patents, Subject Matter, Cell cultures, tissues
    61. Intellectual Property II: Patents, Subject Matter, Cell cultures, tissues http://www.uspto.gov/go/classification/uspc435/sched435.htm#C435S372000
    62. Intellectual Property II: Patents, Subject Matter, Cell cultures, tissues
      • 366 Human
      • 367 HeLa cell or derivative
      • 368 Nervous system origin or derivative
      • 369 Renal origin or derivative
      •   370 Hepatic origin or derivative
      •   371 Epithelial origin or derivative
      • 372 Blood, lymphatic, or bone marrow origin or derivative
      •   372.1 Myeloma origin or derivative
      •   372.2 B-cell or derivative
      •   372.3 T-cell or derivative
      • 373 Method of co-culturing cells
      • 374 Method of storing cells in a viable state
      • 375 Method of regulating cell metabolism or physiology
      •   376 Method of synchronizing cell division  
      • 377 Method of altering the differentiation state of the cell
      • 378 Method of detaching cells, digesting tissue or establishing a primary culture
    63. Intellectual Property II: Patents, Subject Matter, Cell cultures, tissues
    64. Intellectual Property II: Patents, Subject Matter, Cell cultures, tissues
    65. Intellectual Property II: Patents, Subject Matter, Cell cultures, tissues http://www.google.com/advanced_patent_search Osslund Amgen
    66. Bio-Break
    67. Intellectual Property II, Patentable subject matter: Life forms
      • Generally
      • Purified Products of Nature
        • Proteins
          • Case study: Factor VIII case study
        • DNA, nucleic acids
          • Case study: Erythropoietin Case Study
      • Life forms
        • Microbial/Cellular
          • Chakrabarty case
        • Animals, Humans, Chimera, Synthetic
          • Stem cell patent search
        • Plants
          • Case study: Superior Seedless
    68. Intellectual Property II: Patents, Subject Matter, Plants
      • Plant Intellectual Property
      • US Patent and Trademark Office
        • Utility patents
        • Plant Patents
      • US Department of Agriculture
        • Plant Variety Protection
      • Case study: Superior Seedless® – the Prince of Grapes
    69. Intellectual Property II: Patents, Subject Matter, Plants http://www.basf.com/group/corporate/en/function/conversions:/publish/content/news-and-media-relations/images/P101-e-First-ever_drought-tolerant_com_now_one_step_closer_to_farmers.pdf
    70. Intellectual Property II: Patents, Subject Matter, Plants Capturing the Benefits of Genetically Modified Organisms for the Poor, World Development Report 2008: Agriculture for Development http://econ.worldbank.org/WBSITE/EXTERNAL/EXTDEC/EXTRESEARCH/EXTWDRS/EXTWDR2008/0,,contentMDK:21498673~pagePK:64167689~piPK:64167673~theSitePK:2795143,00.html Africa: GMO crops not adopted due to regulatory policy
    71. Intellectual Property II: Patents, Subject Matter, Plants
      • Plant Intellectual Property
      • US Patent and Trademark Office
        • Utility patents
        • Plant Patents
      • US Department of Agriculture
        • Plant Variety Protection
      • Case study: Superior Seedless® – the Prince of Grapes
    72. Intellectual Property II: Patents, Subject Matter, Plants
      • US Patent and Trademark Office
        • Utility patents – Regular patent
          • Genetically modified plants, plant materials, cell culture, anatomical parts, products produced
        • Plant Patents – Asexually reproduced (except tubers)
          • Stable, distinct, propagated
          • Can be found in wild if propagated
      Junius G. Groves; Potato King , Edwardsville, Kans. (c1907) If I were still alive, I would get a utility patent on aspects of my potatoes, but not a plant patent because potatoes are tuberous http://www.google.com/url?q=http://www.blackpast.org/%3Fq%3Daaw/groves-junius-george-1859-1925&ei=fi-WSd-QF4nYsAOdroCPAQ&sa=X&oi=spellmeleon_result&resnum=2&ct=result&cd=1&usg=AFQjCNEObHk54KVspBaCMm-Gkj220TsSJg
    73. Intellectual Property II: Patents, Subject Matter, Plants, Plant patents
      • Anyone who has invented or discovered and asexually reproduced any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber-propagated plant or a plant found in an uncultivated state. 35 USC §161
      • Asexually propagated plants: Tissue culture, rooting of cuttings, by layering, budding, grafting, inarching, etc.; no seeds
      • No tuber-propagated plants: "tuber" defined narrowly as a short, thickened portion of an underground branch, e.g., . Irish potato and the Jerusalem artichoke
      • Application similar to utility patent;
      • Term: 20 years from filing (oversimplified)
      http://www.uspto.gov/web/offices/pac/plant/index.html#1
    74. Intellectual Property II: Patents, Subject Matter, Plants, Plant patents http://www.uspto.gov/web/offices/pac/plant/index.html
    75. Intellectual Property II: Patents, Subject Matter, Plants, Plant patents
    76. Intellectual Property II: Patents, Subject Matter, Plants
      • How to protect plants?
      • US Patent and Trademark Office
        • Utility patents
        • Plant Patents
      • US Department of Agriculture
        • Plant Variety Protection
      • Case study: Superior Seedless® – the Prince of Grapes
    77. Intellectual Property II: Patents, Subject Matter, Plants
      • Plant Variety Protection Act
      • Plant Variety Protection Office (a division of the United States Department of Agriculture)
        • 7 U.S.C. §§ 2321-2582
        • Sexually reproduced or tuberous
        • New, distinct, uniform, stable
        • 20 years new variety; 25 years tree or vine
        • No “brown bagging” or “seed piracy”
      • International Union for the Protection of New Varieties of Plants (UPOV)
    78. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection http://www.ams.usda.gov/SCIENCE/PVPO/PVPO_Act/PVPA2005.pdf http://www.ams.usda.gov/SCIENCE/PVPO/PVPO_Act/PVPA.htm
    79. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection
    80. Intellectual Property II: Patents, Subject Matter, Plants
      • How to protect plants?
      • US Patent and Trademark Office
        • Utility patents
        • Plant Patents
      • US Department of Agriculture
        • Plant Variety Protection
      • Case study: Superior Seedless® – the Prince of Grapes
    81. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection The Prince of Grapes: “Sugarone” , the grape formerly known as Superior Seedless® variety
    82. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection
    83. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection
    84. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection Plant patent expired 1989, grapes should be available for the public to propagate
    85. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection
    86. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection Superior Seedless? Grapes for illustration only
    87. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection Agricultural Marketing Offensive: How to identify grape if varietal name is trademarked?
    88. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection How to identify grape if varietal name is trademarked? Easy - Change the name to one no one knows. . .
    89. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection
    90. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection Use agriculture marketing laws! Say no one can import under a wrong name, and the correct name is trademarked! http://www.eulaw.soton.ac.uk/europriv/Munoz_Proceedings_23_02.htm
    91. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection http://www.actahort.org/members/showpdf?booknrarnr=546_4
    92. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection http://www.dur.ac.uk/resources/deli/annuallecture/2002_DELI_Lecture.pdf Example of EU "private attorney general" equivalent
    93. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection
    94. Intellectual Property II: Patents, Subject Matter, Plants, Plant Variety Protection Superior Seedless- the "Prince" of Grapes
    95. Quiz
      • Patentable? Yes or no
        • Novel isolated genes with known function
        • Novel isolate of naturally occurring marine bacteria purified from culture of seawater microbes
        • Known yeast cells with new DNA genetically modified with new DNA
        • Human stem cells with novel DNA (satisfying all other criteria for patentability)
        • Active ingredient identified and purified from folk remedy spices
        • A genetically modified potato
      Lightening Round
    96. Intellectual Property II, Patentable subject matter: Life forms
      • Generally
      • Purified Products of Nature
        • Proteins
          • Case study: Factor VIII case study
        • DNA, nucleic acids
          • Case study: Erythropoietin Case Study
      • Life forms
        • Microbial/Cellular
          • Chakrabarty case
        • Animals, Humans, Chimera, Synthetic
          • Stem cell patent search
        • Plants
          • Case study: Superior Seedless
    97. END Intellectual Property II, Patentable Subject Matter: Biological compositions and methods CSUCI 2009 BIOL503 K. Pessin Next: Intellectual Property II, Patentable Subject Matter, Electronics
    98. General Patent Examination Links
      • USPTO Manual of Patent Examining Procedures
      • USPTO Examination Guidelines and Examiner Training Materials
      • US Patent and Trademark Office
      • USPTO Patent Search Landing Page
      • Google Patents Advanced Search Interface
      • USPTO Classification 435, Chemistry and Molecular Biology
    99. Search Links
      • United States Patent Office: Patent classification system
      • Drug, Bio-Affecting, and Body Treating Compositions: Class 424
      • Drug, Bio-Affecting, and Body Treating Compositions: Class 514 (subclass of 424)
      • Medical or Lab Equipment: D24
      • Molecular Biology and Microbiology: 435
      • Multicellular Living Organisms and Unmodified Parts Thereof and Related: 800
      • Organic Compounds and Derivatives: 532-570
      • Peptide or Protein Sequence: 930
      • Plant: PLT
      • Surgery: 600-607
    100. Patent Links - International Patent Offices
      • jpo.go.jp
      • justice.gov.il
      • patentsoffice.ie
      • patentoffice.nic …
      • sipo.gov.cn
      • ieeepi.org
      • dpma.de
      • eapo.org
      • espace.com
      • wipo.int
      • patent.gov.uk
      • iponz.govt.nz
      • basmp.gov.ba
      • patentamt.at
      • ipaustralia.gov .…
      • impi.gob.mx
      • inpi.gov.br
      • bpo.bg
      • depatisnet.dpma .
    101. Resources
      • World Intellectual Property Organization, Life Sciences Resources
      • US National Center for Biotechnology Information
    102. Resources
      • Non-Government Organizations and Industry Watchdogs
      • AgBioWorld
      • Center for Science in the Public Interest
      • GeneWatch
      • Greenpeace - Genetic Engineering
    103. Resources
      • Biotech patent law blogs (no particular order)
      • Orange Book Blog
      • Patent Docs
      • Patently Biotech Blog (Biotechnology Industry Organization sponsored)
      • Stem Cell Patents.com
      • Patent Baristas
      • Holman’s Biotech IP Law Blog
    104. Plant Material
      • IMPORTATION OF SMALL LOTS OF SEED WITHOUT PHYTOSANITARY CERTIFICATES USDA/APHIS Federal Register: click HERE
      • CROP COMMERCIALIZATION AND DEREGULATION RESOURCES ( Information Systems for Biotechnology - Virginia Tech)
      • Petitions of Nonregulated Status Granted by APHIS Search USDA Petitions of Nonregulated Status of GM Crops U.S. Database of Completed Regulatory Agency Reviews Commercialized Crops Worldwide
      • FIELD TEST RESOURCES ( Information Systems for Biotechnology - Virginia Tech)
      • USDA field tests of GM crops US EPA notifications 1998-present US EPA notifications 1987-1997 US FDA List of consultations Field tests worldwide
      • INTELLECTUAL PROPERTY PROTECTION
      • USDA/Plant Variety Protection Office Find out if a variety of seed is still protected: www.ars-grin.gov/cgi-bin/npgs/html/pvplist.pl
      • OTHER REGULATORY RESOURCES ( Information Systems for Biotechnology - Virginia Tech)
      • USDA regulatory overview General information on the regulatory process USDA documents US Environmental Protection Agency (EPA) documents US Food and Drug Administration (FDA) documents
      • PLANT VARIETY PROTECTION
      • USDA/Plant Variety Protection Office
      • STATE SEED REGULATIONS
      • http://www.amseed.org/member_SeedRegs.asp American Seed Trade Association creates first comprehensive Guide to State Seed Regulations (01/07)
      • CALIFORNIA What the small-time sellers of seed need to know before they sell seed in California by John Heaton, Senior Agricultural Biologist, California Department of Food and Agriculture , Nursery, Seed & Cotton Program
      • VARIETY NAMING
      • USDA/AMS US variety naming clearance process: http:// www.ams.usda.gov/lsg/seed/varietyname.htm

    + Karol PessinKarol Pessin, 8 months ago

    custom

    483 views, 0 favs, 1 embeds more stats

    Generally
    Purified Products of Nature
    Proteins
    Cas more

    More info about this document

    © All Rights Reserved

    Go to text version

    • Total Views 483
      • 482 on SlideShare
      • 1 from embeds
    • Comments 0
    • Favorites 0
    • Downloads 33
    Most viewed embeds
    • 1 views on http://209.85.173.132

    more

    All embeds
    • 1 views on http://209.85.173.132

    less

    Flagged as inappropriate Flag as inappropriate
    Flag as inappropriate

    Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

    Cancel
    File a copyright complaint
    Having problems? Go to our helpdesk?

    Categories